(Q34617775)

3 August 2017

New era of liver transplantation for hepatitis B: a 17-year single-center experience (English)

1 reference

3 August 2017

liver transplantation

1 reference

1 reference

17

Ronald W Busuttil

1 reference

3 August 2017

6

Sammy Saab

1 reference

3 August 2017

Dean M Anselmo

1

1 reference

3 August 2017

Rafik M Ghobrial

2

1 reference

3 August 2017

Lee Chan Jung

3

1 reference

3 August 2017

Michael Weaver

4

1 reference

3 August 2017

Carlos Cao

5

1 reference

3 August 2017

Greg Kunder

7

1 reference

3 August 2017

Pauline W Chen

8

1 reference

3 August 2017

Douglas G Farmer

9

1 reference

3 August 2017

Hasan Yersiz

10

1 reference

3 August 2017

Angeles Baquerizo

11

1 reference

3 August 2017

Sunil Geevarghese

12

1 reference

3 August 2017

Steven H Han

13

1 reference

3 August 2017

Leonard Goldstein

14

1 reference

3 August 2017

Curtis D Holt

15

1 reference

3 August 2017

Jeffrey A Gornbein

16

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

235

1 reference

3 August 2017

5

1 reference

3 August 2017

611-9; discussion 619-20

1 reference

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

3 August 2017

1 reference

12 December 2020

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

12 December 2020

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

1 reference

12 December 2020

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up

1 reference

12 December 2020

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

1 reference

12 December 2020

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

12 December 2020

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients

1 reference

12 December 2020

Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen

1 reference

12 December 2020

Medical Aspects of Liver Transplantation

1 reference

12 December 2020

Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts

1 reference

12 December 2020

Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations

1 reference

12 December 2020

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients

1 reference

12 December 2020

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

12 December 2020

Liver transplantation for chronic hepatitis B in Asian males

1 reference

12 December 2020

Assessment of lymphokine-activated killer activity and gamma-interferon production in patients with small hepatocellular carcinomas

1 reference

12 December 2020

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

12 December 2020

Should liver transplantation be performed for patients with hepatitis B?

1 reference

12 December 2020

Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma

1 reference

12 December 2020

Multiple organ failure after liver transplantation

1 reference

12 December 2020

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

1 reference

12 December 2020

Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation.

1 reference

12 December 2020

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

12 December 2020

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin

1 reference

12 December 2020

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

1 reference

12 December 2020

Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation

1 reference

12 December 2020

Hepatitis B infection and liver transplantation

1 reference

12 December 2020

Clinical characteristics affecting the outcome of liver retransplantation

1 reference

12 December 2020

Liver transplantation in HBsAg-positive HBV-DNA--negative cirrhotics: immunoprophylaxis and long-term outcome

1 reference

12 December 2020

Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.

1 reference

12 December 2020

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

1 reference

12 December 2020

10.1097/00000658-200205000-00002

Identifiers

DOI

1 reference

3 August 2017

0 references

1 reference